Injectable Business

Jump to

Aurobindo Pharma: Leaner balance sheet and cash flows are bright spots

Key positives for Aurobindo Pharma are sustained performance in the anti-retroviral category and the traction in the US business
Claris Lifesciences net profit up 233 pc at Rs 35 cr in Q3

Claris Lifesciences Ltd today said its consolidated net profit jumped by 233 per cent at Rs 35 crore in Q3 FY2017 as against Rs 15 crore in the corresponding period of last year.
Aurobindo Pharma up 8% on Q1 nos, injectable biz demerger

Aurobindo Pharma has turned profitable with first quarter consolidated net of Rs 18.6 crore as against loss of Rs 128.9 crore in a year ago period. Consolidated net sales jumped 42 percent Y-o-Y to Rs 1,699.6 crore during the quarter.
Business to grow Rs 1000cr in FY11: Stride Arcolab

Stride Arcolab announced it Q3 results for FY11. The company reported a consolidated net profit of Rs 122.4 crore for the year ended 2010 as against Rs 109.7 crore in previous year.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Injectable Business

Aurobindo Pharma: Leaner balance sheet and cash flows are bright spots

Claris Lifesciences net profit up 233 pc at Rs 35 cr in Q3

Aurobindo Pharma up 8% on Q1 nos, injectable biz demerger

Business to grow Rs 1000cr in FY11: Stride Arcolab